NCT00982254 - Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

November 30, 2001

Conditions

Type 2 Diabetes

Interventions

DRUG

Oral insulin

oral insulin capsule formulation (150 U insulin/200 mg 4-CNAB in one capsule); single dose administration of 300 U insulin (in two capsules) and of 150 U insulin (one capsule) on two separate dosing days.

DRUG

regular human insulin

subcutaneous injection of 15 U regular human insulin; single dose administration on one separate dosing visit.

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss